PortfoliosLab logoPortfoliosLab logo
SMMT vs. PHM
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SMMT vs. PHM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SMMT vs. PHM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SMMT
Summit Therapeutics Inc.
8.40%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%
PHM
PulteGroup, Inc.
0.51%8.54%6.22%128.76%-19.22%34.03%12.55%51.33%-20.76%83.43%

Fundamentals

EPS

SMMT:

-$1.24

PHM:

$12.92

Total Revenue (TTM)

SMMT:

$0.00

PHM:

$12.71B

Gross Profit (TTM)

SMMT:

-$15.04M

PHM:

$3.49B

EBITDA (TTM)

SMMT:

-$921.46M

PHM:

$2.33B

Returns By Period

In the year-to-date period, SMMT achieves a 8.40% return, which is significantly higher than PHM's 0.51% return. Over the past 10 years, SMMT has underperformed PHM with an annualized return of 10.54%, while PHM has yielded a comparatively higher 21.81% annualized return.


SMMT

1D
11.66%
1M
14.29%
YTD
8.40%
6M
-8.23%
1Y
-1.71%
3Y*
121.28%
5Y*
25.30%
10Y*
10.54%

PHM

1D
3.42%
1M
-14.10%
YTD
0.51%
6M
-10.62%
1Y
15.32%
3Y*
27.34%
5Y*
18.20%
10Y*
21.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMMT vs. PHM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT
SMMT Risk / Return Rank: 4343
Overall Rank
SMMT Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 4747
Sortino Ratio Rank
SMMT Omega Ratio Rank: 4949
Omega Ratio Rank
SMMT Calmar Ratio Rank: 3939
Calmar Ratio Rank
SMMT Martin Ratio Rank: 4040
Martin Ratio Rank

PHM
PHM Risk / Return Rank: 5757
Overall Rank
PHM Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
PHM Sortino Ratio Rank: 5555
Sortino Ratio Rank
PHM Omega Ratio Rank: 5151
Omega Ratio Rank
PHM Calmar Ratio Rank: 6161
Calmar Ratio Rank
PHM Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMMT vs. PHM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMMTPHMDifference

Sharpe ratio

Return per unit of total volatility

-0.02

0.43

-0.45

Sortino ratio

Return per unit of downside risk

0.65

0.94

-0.29

Omega ratio

Gain probability vs. loss probability

1.10

1.11

-0.01

Calmar ratio

Return relative to maximum drawdown

-0.11

0.82

-0.93

Martin ratio

Return relative to average drawdown

-0.15

1.76

-1.91

SMMT vs. PHM - Sharpe Ratio Comparison

The current SMMT Sharpe Ratio is -0.02, which is lower than the PHM Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of SMMT and PHM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SMMTPHMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.02

0.43

-0.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

0.53

-0.39

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.07

0.60

-0.53

Sharpe Ratio (All Time)

Calculated using the full available price history

0.04

0.26

-0.22

Correlation

The correlation between SMMT and PHM is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SMMT vs. PHM - Dividend Comparison

SMMT has not paid dividends to shareholders, while PHM's dividend yield for the trailing twelve months is around 0.82%.


TTM20252024202320222021202020192018201720162015
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PHM
PulteGroup, Inc.
0.82%0.78%0.75%0.66%1.34%1.00%1.16%1.16%1.46%1.08%1.96%1.85%

Drawdowns

SMMT vs. PHM - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum PHM drawdown of -92.40%. Use the drawdown chart below to compare losses from any high point for SMMT and PHM.


Loading graphics...

Drawdown Indicators


SMMTPHMDifference

Max Drawdown

Largest peak-to-trough decline

-95.75%

-92.40%

-3.35%

Max Drawdown (1Y)

Largest decline over 1 year

-62.26%

-20.06%

-42.20%

Max Drawdown (5Y)

Largest decline over 5 years

-91.96%

-40.99%

-50.97%

Max Drawdown (10Y)

Largest decline over 10 years

-95.75%

-62.11%

-33.64%

Current Drawdown

Current decline from peak

-48.34%

-20.14%

-28.20%

Average Drawdown

Average peak-to-trough decline

-57.79%

-35.56%

-22.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.23%

9.41%

+34.82%

Volatility

SMMT vs. PHM - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 22.65% compared to PulteGroup, Inc. (PHM) at 8.73%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than PHM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SMMTPHMDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.65%

8.73%

+13.92%

Volatility (6M)

Calculated over the trailing 6-month period

43.92%

22.57%

+21.35%

Volatility (1Y)

Calculated over the trailing 1-year period

93.55%

35.76%

+57.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

185.24%

34.60%

+150.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

145.10%

36.38%

+108.72%

Financials

SMMT vs. PHM - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and PulteGroup, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
4.61M
(SMMT) Total Revenue
(PHM) Total Revenue
Values in USD except per share items